In clinical settings, we have found a high rate of human immunodeficiency virus (HIV) drug resistance among antiretroviral‐naive patients for whom the duration of infection was unknown. These high rates were most likely the result of both transmitted resistance and informal antiretroviral use, and they suggest that routine resistance testing among antiretroviral‐naive patients would be a cost‐effective clinical practice.
Cited by
Giovanina M Ellis, Libby C Page, Blaire E Burman, Susan Buskin, Lisa M Frenkel. (2009) Increased Detection of HIV-1 Drug Resistance at Time of Diagnosis by Testing Viral DNA With a Sensitive Assay.
JAIDS Journal of Acquired Immune Deficiency Syndromes 51:3, 283-289
Online publication date: 1-Aug-2009.
CrossRef Davey M Smith, Susanne J May, Samantha Tweeten, Lydia Drumright, Mary E Pacold, Sergei L Kosakovsky Pond, Rick L Pesano, Yolanda S Lie, Douglas D Richman, Simon DW Frost, Christopher H Woelk, Susan J Little. (2009) A public health model for the molecular surveillance of HIV transmission in San Diego, California.
AIDS 23:2, 225-232
Online publication date: 1-Feb-2009.
CrossRef Bluma G Brenner, Michel Roger, Daniela D Moisi, Maureen Oliveira, Isabelle Hardy, Reuven Turgel, Hugues Charest, Jean-Pierre Routy, Mark A Wainberg. (2008) Transmission networks of drug resistance acquired in primary/early stage HIV infection.
AIDS 22:18, 2509-2515
Online publication date: 1-Dec-2008.
CrossRef Vinod Trivedi, Jana Von Lindern, Miguel Montes-Walters, Daniel R. Rojo, Elisabeth J. Shell, Neil Parkin, William A. O'Brien, Monique R. Ferguson. (2008) Impact of Human Immunodeficiency Virus Type 1 Reverse Transcriptase Inhibitor Drug Resistance Mutation Interactions on Phenotypic Susceptibility.
AIDS Research and Human Retroviruses 24:10, 1291-1300
Online publication date: 1-Nov-2008.
CrossRef Lin Liu, Susanne May, Douglas D Richman, Frederick M Hecht, Martin Markowitz, Eric S Daar, Jean-Pierre Routy, Joseph B Margolick, Ann C Collier, Christopher H Woelk, Susan J Little, Davey M Smith. (2008) Comparison of algorithms that interpret genotypic HIV-1 drug resistance to determine the prevalence of transmitted drug resistance.
AIDS 22:7, 835-839
Online publication date: 1-May-2008.
CrossRef Sandra de Meyer, Tony Vangeneugden, Ben van Baelen, Els de Paepe, Herwig van Marck, Gaston Picchio, Eric Lefebvre, Marie-Pierre de Béthune. (2008) Resistance Profile of Darunavir: Combined 24-Week Results from the POWER Trials.
AIDS Research and Human Retroviruses 24:3, 379-388
Online publication date: 1-Apr-2008.
CrossRef Shiro Ibe, Junko Hattori, Seiichiro Fujisaki, Urara Shigemi, Saeko Fujisaki, Kayoko Shimizu, Kazuyo Nakamura, Takejiro Kazumi, Yoshiyuki Yokomaku, Naoto Mamiya, Motohiro Hamaguchi, Tsuguhiro Kaneda. (2008) Trend of Drug-Resistant HIV Type 1 Emergence among Therapy-Naive Patients in Nagoya, Japan: An 8-Year Surveillance from 1999 to 2006.
AIDS Research and Human Retroviruses 24:1, 7-14
Online publication date: 1-Feb-2008.
CrossRef